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Introduction
Infertility is defined as the inability to achieve pregnancy 
after 1 yr of regular unprotected intercourse (Smith et  al., 
2003; Adams et al., 2012). In western countries, one in seven 
couples will seek medical advice for reproductive failure and 
infertility affects 8% to 10% of married or cohabiting couples 
(Allan et al., 1998). A major cause of infertility in mammalian 
females is anovulation. Endocrine hormone imbalances due to 
inappropriate regulation of the hypothalamic–pituitary–go-
nadal axis commonly lead to ovulatory disorders (Figure 1) 
which account for 25% of couples seeking fertility treatment 
(Smith et al., 2003). Understanding what affects the ovulation 
process as well as understanding what might be happening with 
the complex process of folliculogenesis or atresia would allow 
for development of innovative strategies to improve female fer-
tility. Moreover, a better understanding of the physiological 
processes that control ovarian folliclular development and 
leads to the development of a mature oocyte, within a follicle, 
would allow for more optimal assisted reproductive technolo-
gies in livestock and women (Allan et al., 1998).
Why Use Livestock as a Model to Understand 
Anovulation and Female Infertility?
Ovarian research in humans is challenged due to the 
shortage of normal tissue from women of reproductive age 
that has not been subjected to large doses of hormones used in 
vivo for assisted reproductive protocols (Campbell et al., 2003). 
Animal models that can be manipulated or used to obtain spe-
cific cells or tissues are considered valuable as tools to inves-
tigate pathophysiological processes of human diseases. Owing 
to the obvious logistical and ethical limitations on human ex-
perimentation, some relevant queries cannot be answered by 
directly studying affected human patients. In addition, the use 
of animal models can improve our understanding of the patho-
physiology of human diseases and support and test develop-
ment of innovative therapies or treatments.
For decades, researchers have utilized rodents as a model 
for human disease and to understand human physiology. 
As an example of how much rodents are utilized as human 
models, Adams et  al., 2012) reported that 98% of grants 
from the National Institutes of Health and the Department 
of Health and Human Services utilized rodents as the model 
for research. Rodents are a cost-effective model and they have 
short-generation intervals. Novel technologies can be used to 
genetically alter or eliminate genes in specific cells of rodents 
to better understand biological processes critical to biomed-
ical research. However, there are also limitations to the use 
of rodents as biomedical models. When investigating repro-
ductive processes such as folliculogenesis, the rodent is not as 
effective a model as other species in translating to human path-
ologies (Paixao et  al., 2017) (Table 1). For example, rodents 
are considered poly-ovulatory while women are considered 
mono-ovulatory. Additionally, the onset and development of 
folliculogenesis is very different between rodents and women 
(Adams et al., 2012) (Table 1). The rodent reproductive cycle is 
also very short (i.e., 4 d) when compared with 28 d in women 
(Table 1). Finally, rodents have a gestation length of 21 d com-
pared with 9 mo in women (Table 1) and it is very difficult to 
collect sufficient quantities of blood samples from rodents to 
obtain dynamic patterns of endocrine, metabolic, or steroid 
hormones for comparison to women (Soncin et al., 2015).
Several different domestic livestock and nonhuman primate 
models are beneficial to understanding human biological pro-
cesses. Pigs and humans have anatomical and physiological 
similarities that make the pig a good model to study human 
Implications
•  Anovulation is a major cause of infertility in mammalian 
females.
•  Ovarian research in humans is challenging due to the shortage 
of “normal tissue” that can be obtained from women that are 
trying to get pregnant.
•  Livestock animals provide valuable resources to investigate 
the optimal intra-follicular environment required to facilitate 
folliculogenesis and translate to humans.
•  Different livestock models may be more useful depending on 
the specific biological process studied.
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diseases. Pigs are also widely used as biomedical research models 
since many of their organs are of similar size and function as 
human organs (Bassols et  al., 2014). The digestive system in 
pigs is similar to humans and obesity/nutrition-related ques-
tions can be answered in this livestock model (Pedersen et al., 
2013). The pig is a litter-bearing species with a shorter gener-
ation interval, so trans-generational questions may be answered 
in shorter timeframes (Hanson and Skinner, 2016).
The sheep model provides a good resource for addressing 
underlying mechanisms and developing preventative and treat-
ment options that are likely to be of translational value to hu-
mans (Padmanabhan and Veiga-Lopez, 2013) (Table 1). The 
basic anatomy, physiology, and size of sheep allows for physio-
logical monitoring and sampling devices to be inserted during 
gestation to monitor vital signs without loss of pregnancy or 
undue stress. Other species such as cattle are less resilient to this 
invasive monitoring during gestation and often do not main-
tain the pregnancy (Padmanabhan and Veiga-Lopez, 2013). 
Thus, pregnant sheep have been utilized to develop inter-uterine 
gestational restriction models due to their hardy nature and 
ability to maintain pregnancies even when they are being used 
to insert monitoring devices or obtain blood and gestational 
fluids. Thus, pregnant sheep are a major model used to under-
stand prenatal programming and events leading to parturition 
(Grigsby, 2016). One major difference in the pig and sheep is 
that they are poly-ovulatory and women are mono-ovulatory, 
which presents challenges when trying to understand follicle 
development, dominance and oocyte development (Table 1).
Monkeys have been used frequently to investigate human 
diseases since they are nonhuman primates and have 90% to 
93% genetic similarity to humans (Bailey, 2014). They have 
similar biological processes and are excellent models to better 
understand reproduction, disorders, and disease. Monkeys 
also have similar gestation length and have an actual menstrual 
cycle instead of an estrous cycle, and folliculogenesis in mon-
keys is similar to women. However, collection of tissue in mon-
keys at specific follicular developmental phases is difficult and 
monkeys are expensive to house and maintain (Bailey, 2014).
The bovine model system is well suited to understand re-
productive disorders in women. Secretion of hormones during 
the reproductive (estrous) cycle in cattle is very similar to the 
menstrual cycle in women and both species have multiple fol-
licular waves that result in ovulation of a single ovarian fol-
licle (Adams and Pierson, 1995). The size of ovarian follicle is 
similar (15 to 20 mm in diameter) between species and similar 
pathologic conditions can occur in both species (Adams and 
Pierson, 1995) (Table 1). The period of follicle assembly (in the 
developing fetus) occurs through day 133 and 142 of gestation 
in humans and cattle, respectively (Table 1). Furthermore, both 
species undergo this transition at a similar time point coin-
ciding with mid-gestation (Adams et al., 2012). In humans, the 
length of the ovarian luteal phase and the length of gestation 
are also similar to cattle (Table 1). The cow provides an ad-
equate amount of tissue and purified cell populations to con-
duct experiments, which is often difficult to obtain in women. 
Cows can be maintained in large groups of genetically similar 
females under consistent environmental conditions to reduce 
sources of phenotypic variation. Thus, cattle are valuable 
models to elucidate the endocrine and local mechanisms con-
trolling both early and terminal stages of ovarian folliclular de-
velopment in mono-ovulatory species. Experiments conducted 
in the cow can have direct relevance to ovarian reproductive 
disorders in women (Campbell et al., 2003).
Livestock Animals to Study Ovarian Folliclular 
Development and Ovulatory Dysfunction as a 
Biomedical Model for Humans
The mechanisms that underlie the regulation of 
folliculogenesis are still unclear (Juengel et al., 2018) and need 
extensive study to unravel major regulators that control these 
processes. Folliculogenesis begins before birth and continues 
Table 1. Reproductive characteristics of humans, ewes, cows, and rodents
Reproductive characteristics Women Cows Ewes Rodents
Days of gestation that follicle assembly occurs 133 142 100 Shortly after birth
Ovulatory cycle (days) 24–30 17–24 13–19 4–6
Ovulations per cycle 1 1 1–3 12–14
Length of follicular phase (days) 12–14 2–3 2–3 1–3
Length of luteal phase (days) 14–16 15–18 12–14 Depends on whether female  
engages in copulation
Diameter of ovulatory follicle (mm) 18–20 15–20 5–7 0.9–1.1
Duration of gestation (days) 278–282 278–282 142–148 21
+ +
+ +
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&
Figure 1. Conceptual model of how androstenedione affects the normal hypo-
thalamic–anterior pituitary–ovarian axis resulting in anovulation. A4, andro-
stenedione; E2, estradiol-17β; FSH, follicle-stimulating hormone; GnRH, 
gonadotropin-releasing hormone; LH, luteinizing hormone.
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throughout the reproductive lifespan. Ovarian follicles progress 
from primordial to later stages with only a small percentage 
developing to preantral and actually ovulating. A major portion 
of follicles in mammalian species undergoes atresia (Fortune 
et al., 2000). Since failure to ovulate (anovulation) is the largest 
problem with reproduction in female mammals, animal models 
that exhibit disrupted or arrested ovarian follicular development 
provide valuable resources to investigate the intra-follicular en-
vironment that is required to facilitate ovarian folliculogenesis 
and ovulation in humans (Campbell et al., 2003).
One disorder that displays ovarian follicular arrest and 
anovulation is polycystic ovary syndrome (PCOS), a multi-
factorial disorder affecting 9% to 18% (Di Pietro et  al., 2015) 
of reproductive age women. PCOS is often diagnosed when 
hyperandrogenism and infertility occur due to dysfunctional 
follicular maturation and anovulation (Figure 1). The PCOS 
phenotype has been shown to be programmed during fetal devel-
opment (Dumesic et al., 2007) when exogenous androgens have 
been administered. However, the etiology of PCOS is still poorly 
understood. Thus, any information from animal models that have 
similar characteristics to PCOS may help improve current under-
standing of the mechanisms of PCOS initiation and development. 
Women with two of the three criteria are diagnosed with PCOS: 
1)  ovulatory dysfunction (amenorrhea or oligomenorrhea); 
2) hyperandrogenism; and 3) polycystic ovaries. However, several 
laboratories suggest (Abbott et al., 2002) that androgen excess is 
the most important criteria in women diagnosed with PCOS and 
is caused by abnormal theca cell function leading to abnormal 
ovarian follicular development (Abbott et al., 2002).
A recent review (Paixao et al., 2017) identified about 933 
studies using animals as models to study human diseases. 
They focused on 39 studies that used different animal models 
to induce PCOS-like symptoms. These 39 studies included 
18 studies with androgen-induced stimulation, 9 studies with 
estrogens or drugs with estrogen action, including endocrine 
disruptors, and 12 studies with miscellaneous interventions 
(other than androgen and estrogen treatment to induce PCOS 
such as transgenic animals or specific strains). In this review, 
there was a broad difference among the studies concerning 
hormonal interventions, animal species, and developmental 
stage at the time of  the experiments. However, most of  these 
studies showed ovarian morphological changes, with in-
creases in the number of  cystic and antral follicles and the 
absence or decrease in the number of  corpus lutea suggesting 
follicles were not ovulating and the animals were anovula-
tory. As mentioned by this review, most of  these studies pro-
vide important information on physiological processes that 
are altered and may contribute to anovulation in women. In 
addition, these studies may help clarify the mechanisms of 
anovulation in PCOS patients.
Prenatally Androgenized Animals as a Model 
for PCOS
A sheep androgenized model has made significant progress 
in generating new knowledge to increase our understanding 
of how gestational testosterone administration may result in 
a PCOS-like phenotype. Female sheep fetuses exposed to tes-
tosterone during early to mid-gestation exhibited reproductive 
defects including ovarian dysfunction and irreversible morpho-
logical and functional changes in the reproductive axis after 
puberty (Forsdike et  al., 2007; Steckler et  al., 2009). These 
individuals also had disrupted reproductive cycles and an in-
crease in the proportion of growing follicles in the ovarian 
cortex during postnatal life along with metabolic characteris-
tics similar to PCOS when compared with nonandrogenized 
fetuses (Steckler et al., 2009). These studies suggest that repro-
ductive disruptions and PCOS-like symptoms may be caused 
by exposure to prenatal testosterone excess. The results of this 
study may be of relevance to understanding ovarian cycle dis-
ruption and the etiology in women with PCOS (Padmanabhan 
and Veiga-Lopez, 2013).
The prenatally androgenized sheep model was used to study 
ovarian steroidogenesis and follicle formation with different 
breeds of sheep at day 90 (Comim et al., 2015) and 140 (Smith 
et al., 2009). Results of these studies suggested that fetal ex-
posure to testosterone may cause advanced timing of ovarian 
follicle formation. Ovaries from androgenized fetuses col-
lected at 140 d of gestation also observed increased formation 
of ovarian follicles (Smith et  al., 2009). Androgen receptors 
were present in greater concentrations in primordial and pri-
mary follicles in ovaries at day 90 in prenatally androgenized 
fetuses compared with controls, so it is possible that ovarian 
follicular formation did not occur until later in fetal develop-
ment. An interesting shift in steroidogenesis was also detected 
in the ovaries from day 90 prenatally androgenized fetuses 
with an increased proportion of ovarian follicles positive for 
HSD3B2 protein compared with controls. Increased expression 
of HSD3B2 suggests increased activity of the enzyme and a 
shift from the delta-5 to the delta-4 pathway of steroid biosyn-
thesis in ovaries from prenatally androgenized fetuses. These 
data raise key questions about the role of exposure to androgen 
in utero in developmental origins of PCOS and support the 
concept that aberrant ovarian follicular development in PCOS 
is programmed by exposure of the ovary to excess androgen 
during fetal life.
In addition to changes in ovarian follicular development, 
prenatal androgenized ovaries had changes in matrix pro-
teins, which have been shown to contribute to development 
of  persistent ovarian follicles. The increase in matrix proteins 
disrupts the normal tissue remodeling process, availability of 
different growth factors, and communication through gap 
junctions. It also causes thickening of  the ovarian cortex, which 
is often seen in women diagnosed with PCOS (Puttabyatappa 
et  al., 2018). Increases in matrix metalloproteinases may be 
related to increased androgen receptor expression (Ortega 
et  al., 2009). Thus, prenatal androgen exposure may alter 
ovarian folliculogenesis through direct androgen actions and 
also actions of  androgens on remodeling and structure of  the 
ovarian matrix. These changes in structure of  the ovarian ma-
trix may also inhibit the ability of  these follicles to mature and 
to ovulate resulting in the polycystic phenotype.
31July 2019, Vol. 9, No. 3
Exposure to prenatal androgen also results in altered LH se-
cretion, reduced hypothalamic sensitivity to steroid negative feed-
back, and increased insulin secretion due to increased abdominal 
adiposity in rhesus monkeys (Dumesic et al., 2007). These mon-
keys had ovarian morphology similar to PCOS patients with 
hypergonadotropism and polycystic ovaries. Thus, nonhuman 
primates exposed to prenatal androgen recapitulate the metabolic 
and reproductive traits that are often associated with PCOS.
Naturally Occurring Animal Models of 
Androgen Excess
Most of  the animal models for PCOS are developed 
via exogenous androgen treatment (Dumesic et  al., 2007; 
Forsdike et al., 2007; Steckler et al., 2009) or increases in diet 
(Newell-Fugate et al., 2014). There are several animal models 
that have naturally occurring androgen excess and similar 
characteristics to women with PCOS. Naturally occurring 
hyperandrogenism has been described in adult female 
monkeys with elevated LH and anti-Mullerian hormone, 
anovulation, poly-follicular ovaries, and infertility (Abbott 
et  al., 2017). Scientists that have identified this population 
of  monkeys do not know whether these hyperandrogenic in-
dividuals are present in all monkey populations or the per-
centage of  the population that are affected in most monkey 
colonies.
An additional naturally occurring androgen excess 
animal model with PCOS-like characteristics is the High 
A4 cow model described by Summers et  al. (2014). These 
scientists identified a subpopulation of  beef  cows that con-
tain excess intrafollicular androstenedione (A4), theca mo-
lecular phenotypes (greater mRNA abundance CYP17A1, 
CYP11A1, GATA6, and LHCGR) similar to women diag-
nosed with PCOS and subfertility, with a 17% reduced 
calving rate (Summers et al., 2014). Interestingly, these High 
A4 cows have offspring that are 24  kg heavier at weaning 
(Summers et al., 2014). Cattle producers often maintain fe-
males in the herd that wean heavier calves to increase their 
profitability by selling more pounds of  product. Thus, the 
High A4 phenotype may have been a result of  retaining 
these females in the herd with heavier weaned calves and 
selecting for growth over reproduction traits. Investigation 
of  the muscle tissue of  these High A4 cows indicates that 
their myoblasts are not proliferating but are differentiated 
and may be in cell cycle arrest. The fact that High A4 cows 
have calves with heavier weaning weights may suggest that 
the in utero environment the fetus is subjected to inhibits 
growth of  the fetus in utero (through prenatal programming) 
and there is compensatory growth from birth to weaning, 
which is similar to the in utero model of  women with PCOS 
(Barnes et al., 2018).
In High A4 cows, the excess androgen appeared to be 
coming from the ovarian theca cells since mRNA abun-
dance for CYP11A1 and CYP17A1 (Figure 2) was in-
creased along with mRNA abundance for a transcription 
factor GATA6, which upregulated promoter regions of 
Theca Cell
LH
cAMP
PKA
Cholesterol 
(27C)CYP11 
Pregnenolone 
(21C)
17-OH Pregnenolone 
(21C)
CYP17 
(OH-ase)
DHEA 
(19C)
Androstenedione
(19C)
Figure 2. Conceptual model of the normal hormonal steroidogenic pathway in theca cells of the bovine ovary. Cows with excess androstenedione (High A4) 
have increased expression of several gene (e.g., CYP11A1 and CYP17A1) in the steroidogenic pathway.
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both of  these steroidogenic enzymes (Summers et  al., 
2014). In addition to these genes, there was also increased 
mRNA abundance of  LHCGR receptor (Summers et  al., 
2014) (Figure 2). In theca cell lines derived from women 
diagnosed with PCOS, microarray data demonstrated in-
creases in CYP11A1, CYP17A1, GATA6, and LHCGR re-
ceptor (Wood et al., 2004). In addition, the maternal effect 
gene ZAR1 was altered in oocytes from High A4 cows when 
compared with controls in a manner similar to that seen in 
women with PCOS (Summers et  al., 2014) suggesting po-
tential effects on oocyte competence and fertility. Thus, this 
naturally occurring androgen excess High A4 cow model 
has a very similar theca and oocyte molecular phenotype 
to women diagnosed with PCOS and can be used to under-
stand aspects of  androgen excess.
Arrest of  ovarian follicles was also a characteristic of  this 
High A4 population of  cows where there were reduced numbers 
of  tertiary follicles per section, suggesting arrest of  ovarian 
follicles at the antral stage (Summers et al., 2014) (Figure 3). 
In addition to increases in A4 in ovarian follicular fluid, 
there were also increases in testosterone, estrogen, DHEA, 
11-deoxycortocosterone, and 11-deoxycortisol, suggesting 
that steroidogenesis is using the delta-5 pathway normally 
seen to be upregulated in PCOS patients (Rosencrantz et al., 
2011). The High A4 population of  cows has been identified 
in other herds; thus, this model may be more widespread 
than previously described (Summers et al., 2014). It also ap-
pears that the High A4 population cows may constitute 15% 
to 20% of  the herd. Thus, this High A4, natural occurring an-
drogen excess model in beef  cattle, could further our under-
standing of  PCOS and provide potential treatment options 
in the future.
Conclusions
Domestic livestock have tremendous benefits to provide 
avenues to conduct biomedical research. These domestic live-
stock models should be pursued and exploited to provide strat-
egies to increase translation of biomedical research to human 
diseases. Many diseases and disorders are similar in domestic 
livestock and humans and with the appropriate approach could 
be synergistically tested to increase efficiency of application of 
new knowledge and potential therapies.
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